Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications

Por Wang, Jie, Wang, Yow-Ming C., Ahn, Hae-Young
Publicado em 2014

Romiplostim dose–response in patients with myelodysplastic syndromes

Por Perez Ruixo, Juan Jose, Doshi, Sameer, Wang, Yow-Ming C, Mould, Diane R
Publicado em 2013

Bioanalytical Method Validation: Concepts, Expectations and Challenges in Small Molecule and Macromolecule—A Report of PITTCON 2013 Symposium

Por Bashaw, Edward D., DeSilva, Binodh, Rose, Mark J., Wang, Yow-Ming C., Shukla, Chinmay
Publicado em 2014

Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective

Por Wang, Yow-Ming C., Wang, Jie, Hon, Yuen Yi, Zhou, Lin, Fang, Lanyan, Ahn, Hae Young
Publicado no AAPS J (2015)

Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects

Por Wang, Yow-Ming C., Krzyzanski, Wojciech, Doshi, Sameer, Xiao, Jim J., Pérez-Ruixo, Juan Jose, Chow, Andrew T.
Publicado em 2010